A
Anees B. Chagpar
Researcher at Yale University
Publications - 250
Citations - 5983
Anees B. Chagpar is an academic researcher from Yale University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 38, co-authored 227 publications receiving 5028 citations. Previous affiliations of Anees B. Chagpar include Stanford University & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Impact of Financial Burden of Cancer on Survivors' Quality of Life?
Kathleen Fenn,Suzanne B. Evans,Ruth McCorkle,Michael P. DiGiovanna,Lajos Pusztai,Tara Sanft,Erin Hofstatter,Brigid K. Killelea,M. Tish Knobf,Donald R. Lannin,Maysa M. Abu-Khalaf,Nina R. Horowitz,Anees B. Chagpar +12 more
TL;DR: Increased financial burden as a result of cancer care costs is the strongest independent predictor of poor quality of life among cancer survivors.
Journal ArticleDOI
A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
Anees B. Chagpar,Brigid K. Killelea,Theodore N. Tsangaris,Meghan Butler,Karen Stavris,Fangyong Li,Xiaopan Yao,Veerle Bossuyt,Malini Harigopal,Donald R. Lannin,Lajos Pusztai,Nina R. Horowitz +11 more
TL;DR: Cavity shaving halved the rates of positive margins and reexcision among patients with partial mastectomy and caused a significantly lower rate of second surgery for margin clearance than did those in the no-shave group.
Journal ArticleDOI
Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy
Anees B. Chagpar,Lavinia P. Middleton,Aysegul A. Sahin,Peter J. Dempsey,Aman U. Buzdar,Attiqa N. Mirza,F. C. Ames,Gildy V. Babiera,Barry W. Feig,Kelly K. Hunt,Henry Mark Kuerer,Funda Meric-Bernstam,Merrick I. Ross,S. Eva Singletary +13 more
TL;DR: Physical examination, ultrasonography, and mammography were only moderately useful for predicting residual pathologic tumor size after neoadjuvant chemotherapy.
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy
Anees B. Chagpar,Lavinia P. Middleton,Aysegul A. Sahin,Peter J. Dempsey,Aman U. Buzdar,Attiqa N. Mirza,F. C. Ames,Gildy V. Babiera,Barry W. Feig,Kelly K. Hunt,Henry Mark Kuerer,Funda Meric-Bernstam,Merrick I. Ross,S. Eva Singletary +13 more
TL;DR: In this article, the authors evaluated the accuracy of physical examination, ultrasonography, and mammography in predicting residual size of breast tumors following neoadjuvant chemotherapy and found that these methods were only moderately useful for predicting residual pathologic tumor size after neoadjvant chemotherapy, with an accuracy of ± 1 cm in 66% of patients by physical examiners, 75% by ultrasonic, and 70% by mammography.
Journal ArticleDOI
Gender-Related Differences in Outcome for Melanoma Patients
Charles R. Scoggins,Merrick I. Ross,Douglas S. Reintgen,R. Dirk Noyes,James S. Goydos,Peter D. Beitsch,Marshall M. Urist,Stephan Ariyan,Jeffrey J. Sussman,Michael J. Edwards,Anees B. Chagpar,Robert C.G. Martin,Arnold J. Stromberg,Lee Hagendoorn,Kelly M. McMasters +14 more
TL;DR: Male gender is associated with a greater incidence of unfavorable primary tumor characteristics without an increased risk for nodal metastasis, and gender is an independent factor affecting survival.